| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $21,430,735 ) (Continued on the next page) |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | U01AI168622 | One-Health Approach to Study Human Fasciola hepatica Transmission and Inform Strategic Control | 000 | 3 | NIH | 3/12/2024 | $429,294 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | D43TW010331 | Colombia-U.S. Fogarty training program on the impact of emerging zoonotic and vector-borne diseases in acute undifferentiated febrile illnesses | 000 | 9 | NIH | 2/26/2024 | $50,000 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DA040621 | Small molecule modulators of ?FosB | 000 | 9 | NIH | 3/22/2024 | $552,629 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG054025 | Formation and Propagation of Tau Oligomeric Strains in Alzheimer's Disease | 000 | 8 | NIH | 4/18/2024 | $776,725 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | UG1HD053097 | Maternal-Fetal Medicine Units Network | 000 | 20 | NIH | 3/22/2024 | $227,522 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | UL1TR001439 | UTMB Clinical and Translational Science Award | 001 | 10 | NIH | 4/17/2024 | $428,636 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | UL1TR001439 | UTMB Clinical and Translational Science Award | 000 | 10 | NIH | 3/25/2024 | $3,857,736 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | TL1TR001440 | NRSA Training Core | 000 | 10 | NIH | 3/25/2024 | $421,620 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | KL2TR001441 | Institutional Career Development Core | 000 | 10 | NIH | 3/27/2024 | $435,740 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | T35AI078878 | Infectious Diseases and Inflammatory Disorders Training Program | 000 | 14 | NIH | 11/7/2023 | $66,385 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01MH077303 | Synaptic Organizers: Dynamic Regulation of Trans-synaptic Bridges | 001 | 17 | NIH | 12/8/2023 | $695,210 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG018016 | The Mexican Health Aging Study (MHAS) | 000 | 17 | NIH | 2/2/2024 | $1,964,992 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R25HL161715 | The University of Texas Medical Branch Summer Institute in Biostatistics and Data Science (UTMB-SIBDS) | 000 | 3 | NIH | 1/12/2024 | $75,000 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01NS125778 | Role of microglia in neural infection | 000 | 3 | NIH | 12/7/2023 | $464,451 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG077253 | The Role of Ubiquitination in Tau Oligomers Pathogenesis | 000 | 3 | NIH | 4/18/2024 | $748,330 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | D43TW012246 | Training and Research on Arboviruses and Zoonoses In Nigeria and Sierra Leone (TRAIN) | 000 | 3 | NIH | 2/20/2024 | $198,400 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | D43TW012246 | Training and Research on Arboviruses and Zoonoses In Nigeria and Sierra Leone (TRAIN) | 000 | 3 | NIH | 2/20/2024 | $50,000 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DA053472 | Novel Addiction Neurocircuits in Cocaine Taking | 000 | 3 | NIH | 1/17/2024 | $439,957 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI158422 | Ehrlichia Notch SLiM-activated oncoprotein inhibition of apoptosis | 000 | 3 | NIH | 11/3/2023 | $360,000 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | DP2AI154410 | Revealing the Biophysics of the Germinal Center Microenvironment | 000 | 3 | NIH | 11/9/2023 | $432,001 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DA052263 | AIM(2)ing at the inflammasome: Impact of MAVS signaling in cocaine-and HIV-1 induced neuroinflammation | 000 | 4 | NIH | 2/27/2024 | $534,501 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG070255 | Mechanisms of Synaptic Protection in Cognitive Resilence to Alzheimer's Disease Neuropathology | 000 | 4 | NIH | 3/8/2024 | $398,455 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG063945 | Phospholipase D1 Mediated Early Events Affecting Synaptic Dysfunction in Alzheimer's Disease and Related Dementia | 000 | 5 | NIH | 4/17/2024 | $395,000 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R25GM134990 | PREPing for SUCCESS | 000 | 5 | NIH | 3/22/2024 | $220,378 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | K01HD101589 | Standardized Patient Assessment across Post-Acute Care: Opportunities and Challenges | 000 | 5 | NIH | 3/19/2024 | $126,212 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01HD100729 | Intercellular interactions define cell migrations and transitions that maintain fetal membrane homeostasis | 000 | 5 | NIH | 2/6/2024 | $395,940 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI150917 | Safety and immunogenicity of a novel Rift Valley fever candidate vaccine, RVax-1 | 000 | 5 | NIH | 3/11/2024 | $347,513 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI146227 | Mechanistic function of HCV NS5A targeted by the potent inhibitors | 000 | 5 | NIH | 1/10/2024 | $499,073 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01CA247595 | Bimodal Intraoral imaging device for detection of oral epithelial neoplasia | 001 | 5 | NIH | 4/17/2024 | $23,418 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01CA247595 | Bimodal Intraoral imaging device for detection of oral epithelial neoplasia | 000 | 5 | NIH | 11/16/2023 | $421,504 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R35GM130326 | Dynamics of DNA scanning and recognition by proteins | 000 | 6 | NIH | 1/25/2024 | $536,000 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R56NS073976 | DNA double strand break repair deficiency and neurodegeneration | 000 | 10 | NIH | 3/15/2024 | $536,032 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DA060221 | Frustration effects on drug taking | 000 | 1 | NIH | 4/2/2024 | $400,000 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R61AI179997 | Generation of Orientia tsutsugamushi mutant strains for pathogenesis research | 000 | 1 | NIH | 12/15/2023 | $280,000 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | U24FD007821 | An Educational Program to Enhance Data Quality and Integrity for Regulated Studies Supporting the Advancement of Medical Countermeasures for High Consequence Pathogens | 000 | 2 | FDA | 12/12/2023 | $480,000 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01NS131507 | The role of neuro-immune interactions in PACAP induced migraine | 000 | 1 | NIH | 1/10/2024 | $499,611 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R13AI183719 | Tropical and Emerging Infectious Diseases for the Clinician and Translational Investigator | 000 | 1 | NIH | 3/18/2024 | $6,000 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AI176297 | Nanoparticle-encapsulated Epigenetic Inhibitors for Treatment of Inflammatory Bowel Diseases | 000 | 1 | NIH | 1/29/2024 | $214,129 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AI176297 | Nanoparticle-encapsulated Epigenetic Inhibitors for Treatment of Inflammatory Bowel Diseases | 001 | 1 | NIH | 2/22/2024 | $0 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG081282 | Nursing homes' visitation bans during the COVID-19 pandemic: Effectiveness and consequences. | 001 | 2 | NIH | 1/31/2024 | $311,715 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AG081900 | Comparative effectiveness of pelvic floor muscle training, Mirabegron, and Trospium among older women with urgency urinary incontinence and high fall risk: a feasibility randomized clinical study. | 001 | 2 | NIH | 4/18/2024 | $193,067 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01GM145925 | Mitochondrial translesion DNA synthesis | 000 | 2 | NIH | 3/20/2024 | $300,371 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R00AI156012 | Viral factors responsible for Lassa virus pathogenicity | 001 | 4 | NIH | 3/15/2024 | $249,000 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AG082230 | Role of microglia in cognitive resilience to AD | 000 | 2 | NIH | 2/1/2024 | $108,000 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01GM149683 | Impact of ATR's role in translesion synthesis on prevention of DNA damage induced mutagenesis and chromosomal instability | 000 | 2 | NIH | 12/27/2023 | $288,000 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG075208 | Identifying the Causes of the Stagnation in National U.S. Cardiovascular Disease Mortality | 000 | 2 | NIH | 1/18/2024 | $335,034 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI176670 | Porous silicon microparticle-based subunit vaccines for SARS-CoV-2 | 000 | 2 | NIH | 1/18/2024 | $604,067 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R61AG075725 | tRNA-derived RNA Fragments (tRF) as Prognostic and Diagnostic Biomarkers for Alzheimer?s Disease | 000 | 2 | NIH | 2/23/2024 | $799,998 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AI171664 | PIWIL4 and piRNAs in RSV Infection | 000 | 2 | NIH | 1/17/2024 | $180,000 |
|
